تحميل
NYSEHealthcareMedical - Healthcare Information Services
أحدث البيانات المتاحة
4.14 US$
+0.30 US$ · +7.81%
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
الإغلاق السابق
4.14 US$
+0.30 US$ · +7.81%
قبل افتتاح السوق
4.14 US$
0.00 US$ · 0.00%
8 أكتوبر، 5:51 ص ET
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
نطاق اليوم
السعر الحالي 4.14 US$
نطاق 52 أسبوعًا
السعر الحالي 4.14 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
احتفاظ
تقييم
36
مرتفع السعر
المشاعر
63
صعودي
المخاطر
63
مخاطر مرتفعة
الزخم
64
زخم متزايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
نطاق اليوم
السعر الحالي 4.14 US$
نطاق 52 أسبوعًا
السعر الحالي 4.14 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 | السنة المالية 2021 |
|---|---|---|---|---|---|
| الإيرادات | 1.88 مليار USD | 2.55 مليار USD | 1.96 مليار USD | 1.35 مليار USD | 907.96 مليون USD |
| تكلفة البضاعة المباعة | 1.59 مليار USD | 2.19 مليار USD | 1.5 مليار USD | 1.04 مليار USD | 657.55 مليون USD |
| الربح الإجمالي | 284.03 مليون USD | 367.35 مليون USD | 460.47 مليون USD | 316.58 مليون USD | 250.41 مليون USD |
| البحث والتطوير | — | — | — | 27 مليون USD | — |
| مصاريف البيع والمصاريف العمومية والإدارية | 288.47 مليون USD | 263.05 مليون USD | 358.11 مليون USD | 269.27 مليون USD | 219.5 مليون USD |
| نفقات التشغيل | 288.47 مليون USD | 407.84 مليون USD | 531.68 مليون USD | 312.94 مليون USD | 292.82 مليون USD |
| دخل الفوائد | 4.19 مليون USD | 5.54 مليون USD | 5.26 مليون USD | 1.37 مليون USD | 407 ألف USD |
| مصاريف الفوائد | 57.47 مليون USD | 24.72 مليون USD | 54.21 مليون USD | 15.57 مليون USD | 25.43 مليون USD |
| الاستهلاك والإطفاء | 115.85 مليون USD | 118.37 مليون USD | 123.42 مليون USD | 90.25 مليون USD | 60.04 مليون USD |
| الدخل التشغيلي | −4.44 مليون USD | −40.49 مليون USD | −71.21 مليون USD | 3.64 مليون USD | −42.41 مليون USD |
| صافي الدخل | −534.51 مليون USD | −61.62 مليون USD | −113.04 مليون USD | −19.16 مليون USD | −37.6 مليون USD |
تم تحديث حقائق الشركة 8 أكتوبر 2026.
أحدث النتائج المعلنة
أحدث النتائج المعلنة
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
متوسط الهدف
7.00 US$
ارتفاع محتمل بنسبة 69.08%صناديق متداولة تفصح عن تعرضها لهذا السهم.
Vanguard Morningstar Total Stock Market ETFVTI15.23 مليون0.00%2.3 ترليون USD0.03%381.03 US$-0.40%
iShares Russell 2000 ETFIWM11.28 مليون0.01%78.56 مليار USD0.19%277.7 US$-1.29%
Vanguard Extended Market ETFVXF5.93 مليون0.01%95.4 مليار USD0.05%233.49 US$-1.56%
Schwab Fundamental U.S. Small Company Index ETFFNDA4.38 مليون0.05%8.84 مليار USD0.25%35.40 US$-1.31%
Janus Henderson Small/Mid Cap Growth Alpha ETFJSMD3.15 مليون0.30%1.04 مليار USD0.30%90.6034 US$-1.34%
Vanguard Russell 2000 ETFVTWO2.96 مليون0.02%18 مليار USD0.06%112.21 US$-1.26%
Schwab U.S. Small-Cap ETFSCHA2.07 مليون0.01%22.01 مليار USD0.03%32.61 US$-1.47%
Vanguard U.S. Value Factor ETFVFVA1.56 مليون0.18%957.4 مليون USD0.13%152.24 US$-0.64%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFSchwab Fundamental U.S. Small Company Index ETFFNDAJanus Henderson Small/Mid Cap Growth Alpha ETFJSMDVanguard Russell 2000 ETFVTWOSchwab U.S. Small-Cap ETFSCHAVanguard U.S. Value Factor ETFVFVAالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.
